Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539775 of 542236 entries
View as:

Try Walking a Mile in These Shoes: Activity Level of Lower Extremity Amputees

Phase: N/A Priority: Normal
NCT ID: NCT00439088 Org: User:
Start: 07/31/05 End: 08/31/05 Due: 08/31/06

Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00507650 Org: User:
Start: 09/30/03 End: 03/31/07 Due: 03/31/08

The Effects of Protein Supplementation With or Without Urolithin A During Single-leg Immobilization

Phase: N/A Priority: Normal
NCT ID: NCT05814705 Org: User:
Start: 06/01/23 End: 04/30/25 Due: 04/30/26

The Effect of Foot Massage on Anxiety, Pain and Comfort Level

Phase: N/A Priority: Normal
NCT ID: NCT05850897 Org: User:
Start: 04/30/24 End: 12/30/24 Due: 12/30/25

Effects of Individual, Dyadic, and Collaborative Plans on Physical Activity in Parent-Child Dyads

Phase: N/A Priority: Normal
NCT ID: NCT02713438 Org: User:
Start: 04/30/16 End: 12/31/23 Due: 12/31/24

The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

Phase: N/A Priority: Normal
NCT ID: NCT03945968 Org: User:
Start: 07/01/19 End: 02/28/26 Due: 02/28/27

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT03233204 Org: User:
Start: 09/14/17 End: 06/30/24 Due: 06/30/25

Physiologic Phacofluidics: Ghost Protocol

Phase: N/A Priority: Normal
NCT ID: NCT06904404 Org: User:
Start: 01/01/24 End: 10/31/24 Due: 10/31/25

Knee Osteoarthritis (OA) Project Treatment Versus Conventional Physical Therapy in the Treatment of Knee OA Patients

Phase: N/A Priority: Normal
NCT ID: NCT01490606 Org: User:
Start: 01/31/12 End: 12/31/12 Due: 12/31/13

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02838836 Org: User:
Start: 07/01/16 End: 12/01/26 Due: 12/01/27

The Effect of Oxycodone to the Placental Circulation at Early Labour

Phase: N/A Priority: Normal
NCT ID: NCT02573831 Org: User:
Start: 02/01/15 End: 12/31/23 Due: 12/31/24

Performance Evaluation of the ex Utero Cord Blood Collection Technique: Procedure, Quality and Results

Phase: N/A Priority: Normal
NCT ID: NCT05836974 Org: User:
Start: 09/01/23 End: 09/25/24 Due: 09/25/25

Genetic Predictors of Renal Dysfunction Following Heart Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01686191 Org: User:
Start: 08/31/12 End: 12/31/25 Due: 12/31/26

Antihypertensive Deprescribing in Long-term Care

Phase: N/A Priority: Normal
NCT ID: NCT05047731 Org: User:
Start: 09/20/21 End: 06/30/25 Due: 06/30/26

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06438445 Org: User:
Start: 07/30/24 End: 04/05/26 Due: 04/05/27

Intercellular Adhesion Molecule-1 and TNF-α in Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05408325 Org: User:
Start: 02/01/21 End: 02/12/22 Due: 02/12/23

Effect of Postural Realignment on Postural Stability and Visual Reliance in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05032274 Org: User:
Start: 01/12/22 End: 03/03/23 Due: 03/03/24

Performance of Safety of SILKAM® Suture Material in Oral Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05296902 Org: User:
Start: 09/21/22 End: 11/16/23 Due: 11/16/24

Ultrasound-based Imaging to Detect Early Changes of Hard and Soft Tissue Around Immediately Placed Implants With or Without Soft Tissue Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT05330702 Org: User:
Start: 01/17/23 End: 05/31/26 Due: 05/31/27

Development of Childhood Anti-Influenza Immunity

Phase: N/A Priority: Normal
NCT ID: NCT03673345 Org: User:
Start: 09/25/18 End: 12/22/20 Due: 12/22/21

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

Phase: N/A Priority: Normal
NCT ID: NCT06417177 Org: User:
Start: 06/03/24 End: 07/31/25 Due: 07/31/26

TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Phase: N/A Priority: Normal
NCT ID: NCT05002998 Org: User:
Start: 09/16/21 End: 04/15/26 Due: 04/15/27

Endometrial Effects of Lipiodol

Phase: N/A Priority: Normal
NCT ID: NCT03542331 Org: User:
Start: 03/01/18 End: 01/31/20 Due: 01/31/21

Mepolizumab in Nasal Polyposis

Phase: N/A Priority: Normal
NCT ID: NCT01362244 Org: User:
Start: 05/12/09 End: 12/05/14 Due: 12/05/15

COVID-19 Self-Testing Through Rapid Network Distribution

Phase: N/A Priority: Normal
NCT ID: NCT04797858 Org: User:
Start: 05/05/21 End: 11/29/23 Due: 11/29/24